Jiangsu Durui Pharmaceutical

Jiangsu Durui Pharmaceutical is a China-based pharmaceutical company headquartered in Nanjing, dedicated to the development and manufacturing of high-end generic and innovative small molecule drugs. The company has established a strong commercial presence in the cardiovascular and metabolic therapeutic areas with its portfolio of statin medications, including Rosuvastatin and Pitavastatin. Durui operates integrated R&D and manufacturing facilities that adhere to international GMP standards, ensuring high-quality production for both domestic and international markets. In addition to its generic business, the company is advancing a pipeline of novel drug candidates, such as DR-101, targeting oncology and other complex diseases. Through its focus on innovation and quality, Jiangsu Durui Pharmaceutical aims to provide affordable and effective therapeutic solutions to patients globally.